Purpose Announces Corrections to Risk Ratings for Certain
TORONTO, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Purpose Investments Inc. (“Purpose”) today announced changes to the risk ratings for 16 public investment...
Purpose annonce des corrections dans les notations de
TORONTO, 06 sept. 2024 (GLOBE NEWSWIRE) -- Investissements Purpose Inc. (« Purpose ») a annoncé aujourd’hui des changements au niveau de risque de 16...
Taysha Gene Therapies Announces Inducement Grant Under
DALLAS, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated virus...
Airship AI Announces Closing of $8.0 Million Public
REDMOND, Wash., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Airship AI Holdings, Inc. (NASDAQ: AISP) (“Airship AI” or the “Company”), a leader in...
Arcutis Biotherapeutics Reports Inducement Grants Under
WESTLAKE VILLAGE, Calif., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations...
Mural Oncology Reports Inducement Grants Under Nasdaq
WALTHAM, Mass. and DUBLIN, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational...
Independent Proxy Advisory Firm ISS Recommends XORTX
CALGARY, Alberta, Sept. 03, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt:...
Intellia Therapeutics Reports Inducement Grants under
CAMBRIDGE, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine...
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq
BOSTON, Sept. 03, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare...
FINALTO UNVEILS ADVANCED WHITE LABEL SOLUTION FOR BROKERS
Finalto South Africa has unveiled its newly revamped White Label solution that allows market participants to start their own brokerages in record time, as...
Abeona Therapeutics® Announces New Employee Inducement
CLEVELAND, Sept. 02, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who...
Applied Digital Issues $53.2 Million Convertible Preferred
DALLAS, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Applied Digital Corporation (Nasdaq: APLD) (“Applied Digital” or the “Company”), a designer, builder, and operator...
